Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Authors
»
Aaron Lorenzo
Articles by Aaron Lorenzo
NeoPharm, FDA Define Plans For IL13's Phase III Program
Feb. 9, 2004
By
Aaron Lorenzo
Nuvelo Adds Dendreon's Heart Product To Thickening Pipeline
Feb. 6, 2004
By
Aaron Lorenzo
Nuvelo Adds Dendreon's Heart Product To Thickening Pipeline
Feb. 6, 2004
By
Aaron Lorenzo
Caprion Pairs Proteomics-Based Lung Cancer Work With Abbott
Feb. 5, 2004
By
Aaron Lorenzo
Caprion Pairs Proteomics-Based Lung Cancer Work With Abbott
Feb. 5, 2004
By
Aaron Lorenzo
Liver Drug Developer Metabasis Files Registration For $86M IPO
Feb. 4, 2004
By
Aaron Lorenzo
Liver Drug Developer Metabasis Files Registration For $86M IPO
Feb. 4, 2004
By
Aaron Lorenzo
Targeted Genetics Adding $25.5M To Cash Via Public Stock Offering
Feb. 3, 2004
By
Aaron Lorenzo
Targeted Genetics Adding $25.5M To Cash Via Public Stock Offering
Feb. 3, 2004
By
Aaron Lorenzo
Palatin Raises $22.7M For Drug Trials Via Stock, Warrants Sale
Feb. 2, 2004
By
Aaron Lorenzo
Previous
1
2
…
155
156
157
158
159
160
161
162
163
…
237
238
Next
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe